Morgan Stanley Expects Strong Growth Report from Colgate-Palmolive

In a report published Friday, Morgan Stanley analyst Dara Mohsenian reiterated the Overweight rating and $70.00 price target on Colgate-Palmolive CL. In the report, Morgan Stanley noted, “We expect Colgate to post organic sales growth at the high end of mega-cap peers given its greater exposure to higher-growth emerging market geographies and personal care product categories, a more defensive business mix, less demand elasticity to pricing, and a strong innovation pipeline.” Colgate-Palmolive closed on Thursday at $63.22.